has been cited by the following article(s):
[1]
|
Stratégies thérapeutiques post-chirurgicales actuelles dans les cancers de l’ovaire en première ligne de traitement
Bulletin du Cancer,
2023
DOI:10.1016/j.bulcan.2023.01.020
|
|
|
[2]
|
Real-world experience of pembrolizumab and lenvatinib in recurrent endometrial cancer: A multicenter study in Korea
Gynecologic Oncology,
2022
DOI:10.1016/j.ygyno.2022.02.020
|
|
|
[3]
|
Real-world experience of pembrolizumab and lenvatinib in recurrent endometrial cancer: A multicenter study in Korea
Gynecologic Oncology,
2022
DOI:10.1016/j.ygyno.2022.02.020
|
|
|